18.48
Theravance Biopharma Inc Borsa (TBPH) Ultime notizie
Theravance's Q3 Earnings Surpass Estimates, Revenues Match - MSN
[Form 4] Theravance Biopharma, Inc. Insider Trading Activity - Stock Titan
CEO Winningham Surrenders 56,817 Of Theravance Biopharma Inc [TBPH] - TradingView
Can Theravance Biopharma Inc. stock beat analyst upgrades - newser.com
Why pension funds invest in Theravance Biopharma Inc. (0TB) stock2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Is Theravance Biopharma Inc. stock attractive for passive investors2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Theravance Biopharma (TBPH) is a Top-Ranked Growth Stock: Should You Buy? - MSN
Why Theravance Biopharma Inc. stock is rated strong buy2025 Fundamental Recap & Accurate Trade Setup Notifications - newser.com
Theravance Biopharma to host virtual KOL event on ampreloxetine study - Investing.com
Theravance Biopharma to host virtual KOL event on ampreloxetine study By Investing.com - Investing.com India
Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025 - 富途牛牛
Is Theravance Biopharma Inc. (0TB) stock a fit for income portfoliosJuly 2025 Review & Technical Analysis for Trade Confirmation - newser.com
How Theravance Biopharma Inc. (0TB) stock reacts to fiscal policiesWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
Theravance Biopharma Inc. stock trendline breakdownQuarterly Profit Report & Accurate Technical Buy Alerts - newser.com
Is Theravance Biopharma Inc. stock cheap at current valuation2025 Volume Leaders & Weekly Return Optimization Alerts - newser.com
Will a bounce in Theravance Biopharma Inc. offer an exit2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
Can Theravance Biopharma Inc. stock deliver consistent earnings growthQuarterly Performance Summary & Reliable Price Breakout Signals - newser.com
Theravance Biopharma Inc. stock retracement – recovery analysisTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Theravance Biopharma (NASDAQ: TBPH) to Join Evercore, Oppenheimer Investor Conferences - Stock Titan
News impact scoring models applied to Theravance Biopharma Inc.Earnings Overview Summary & AI Driven Price Predictions - newser.com
What momentum shifts mean for Theravance Biopharma Inc.2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
Comparing Theravance Biopharma Inc. in custom built stock radarsTake Profit & Weekly High Conviction Trade Ideas - newser.com
Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsJuly 2025 Breakouts & Expert-Curated Trade Recommendations - newser.com
What indicators show strength in Theravance Biopharma Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
BTIG Hosts Virtual Meeting Featuring (TBPH) on November 24 - GuruFocus
Why Theravance Biopharma Inc. (0TB) stock benefits from AI revolutionJuly 2025 Update & High Yield Stock Recommendations - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):